Gov. Kemp: UCB to Invest $2 Billion in Georgia, Establish First U.S. Manufacturing Facility

ATLANTA ~ In a major announcement today, Governor Brian P. Kemp revealed that global biopharmaceutical company UCB, Inc. will be investing $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. This investment is expected to create 330 new jobs over the next few years at the Rowen Foundation's state-of-the-art science and learning campus in Gwinnett County.

Governor Kemp expressed his excitement about this partnership with UCB, stating, "When we met with UCB leadership earlier this year in Belgium, we discussed how the Peach State would be the right partner for their visionary plans in the U.S. that will benefit both patients and hardworking Georgians." He also noted that this investment is a significant milestone for Georgia's life sciences industry and solidifies the state as a hub of innovation.

UCB, headquartered in Belgium, currently has its North American headquarters in Smyrna and employs over 400 people. The company specializes in neurology and immunology.

More on EntSun News

• Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
• Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
• Billy Bob Thornton & The Boxmasters Coming to The Eichelberger Performing Arts Center This August
• Harlem Globetrotters & Keepsake Trading Cards Launch Centennial Trading Card Collection
• Colette Barris's Open Letter To Revolt's Detavio Samuels 'The BlackPrint' Interview Of Kenya Barris

UCB's CEO Jean-Christophe Tellier shared his confidence in the company's long-term growth and commitment to the United States, saying, "By investing in Georgia, where our U.S. headquarters have been based for more than three decades, we are strengthening our biologics manufacturing capabilities, supporting our innovation pipeline, and creating high-quality jobs." He also mentioned that this project is expected to generate approximately $5 billion in total economic impact for the region.

The new manufacturing facility will be located at Rowen, a planned community spanning 2,000 acres in metro Atlanta designed to foster collaboration and innovation. The campus will utilize cutting-edge technology such as AI, robotics, and automation while prioritizing efficiency and sustainability.

Gwinnett County Board of Commissioners Chairwoman Nicole Love Hendrickson expressed her excitement about UCB's decision to invest in Gwinnett County. She stated that this investment aligns with the county's vision for Rowen as a hub for collaboration and discovery. She also highlighted Gwinnett's diverse and skilled talent pool, which she believes will be a valuable asset to UCB.

More on EntSun News

• EFA Announces 2026 Editorial Rate Chart
• NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
• Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
• SeeVideo.dance Goes Live: Dual-Engine AI Video Studio Brings Seedance 2.0 and Kling 3.0 to Creative Professionals
• Shoutout Joseph Neibich aka Nybyk

Katie Kirkpatrick, President and CEO of the Metro Atlanta Chamber, also praised UCB's decision to invest in Gwinnett County. She stated, "UCB's innovation, talent, and strategic investment show that metro Atlanta is not just a hub for life sciences today, but a place where the breakthroughs of tomorrow are taking shape."

The Georgia Department of Economic Development (GDEcD) played a crucial role in securing this investment. Project Director EJane Caraway represented GDEcD's Global Commerce team in partnership with Partnership Gwinnett, Metro Atlanta Chamber, Georgia Quick Start, and Georgia Power.

GDEcD Commissioner Pat Wilson emphasized Georgia's growing life sciences ecosystem and collaborative approach to economic development as key factors in attracting companies like UCB. He stated, "Together with our focus on being the Top State for Talent, it's why innovators like UCB choose Georgia to advance discoveries from R&D to real-world impact."

This significant investment by UCB is not only a testament to the strength of Georgia's life sciences industry but also highlights the state's commitment to fostering innovation and creating high-quality jobs. With this new manufacturing facility at Rowen, UCB is poised to continue its legacy of biopharmaceutical innovation for years to come.

---

Show All News | Report Violation